Macular Disease Foundation Australia (MDFA) is seeking to clear up any confusion around deferring eye appointments during lockdown.
Macular Disease Foundation Australia (MDFA) has awarded more than $1 million in research funding to eight promising projects, in a ceremony marking 10 years of significant advances in the search for a cure to Australia’s leading cause of blindness.
On 1st October 2021, Beovu® became the third anti-VEGF drug to be subsidized by the Pharmaceutical Benefits Scheme for the treatment of wet age-related macular degeneration.
In the August 2021 edition of Macula Matters, MDFA’s email newsletter for eye health professionals, we’re excited to share our new CPD course on diabetic eye disease for optometrists, available now through MDFA’s website as well as a meeting with the Health Minister as well as a case study from the Centre For Eye Health.
We aim to respond to your request by the next business day. If you require assistance sooner, please call our National Helpline on 1800 111 709 (Monday - Friday 9-5pm AEST).
If your query is about an eye emergency - including sudden changes to your vision or eye pain - please contact your optometrist or ophthalmologist as soon as possible.Great!